Emerging roles and mechanisms of small nucleolar RNA in cardiovascular diseases: research progress

Yuzhe Han , Jiazhen Sui , Hongyu Cao , Xinru Jiang , Haifeng Zhang , Yu Wang , Jianxun Wang

Vessel Plus ›› 2026, Vol. 10 ›› Issue (1) : 26

PDF
Vessel Plus ›› 2026, Vol. 10 ›› Issue (1) :26 DOI: 10.20517/2574-1209.2025.145
Review
Emerging roles and mechanisms of small nucleolar RNA in cardiovascular diseases: research progress
Author information +
History +
PDF

Abstract

Small nucleolar RNAs (snoRNAs) are increasingly recognized as key regulatory factors in cardiovascular disease (CVD), with functions that extend far beyond the traditional scope of ribosomal RNA modification. This review synthesizes current knowledge regarding the biology of snoRNAs and their emerging roles in CVD, aiming to provide a clear theoretical framework for their pathogenic mechanisms and clinical significance. We first discuss the biogenesis, classification, and functional diversity of snoRNAs, covering both classical modification roles and non-classical functions such as the regulation of messenger RNA splicing, participation in the DNA damage response, and the generation of snoRNA-derived small RNAs. In CVD, snoRNAs exhibit spatiotemporal dysregulation and are extensively involved in pathological processes ranging from congenital heart defects and cardiomyopathy to coronary artery disease, myocardial infarction, arrhythmias, and heart failure. Specific gene clusters, particularly 14q32 snoRNAs, repeatedly emerge as key regulatory nodes in processes such as vascular remodeling and platelet activation. However, the majority of dysregulated snoRNAs remain orphaned with unknown targets, limiting our understanding of their mechanisms and clinical translation. We emphasize that combining computational modeling with multi-omics approaches can accelerate target identification and functional elucidation. Finally, we systematically examine the opportunities and challenges facing the clinical translation of snoRNA research, including their potential as dynamic biomarkers, limitations of detection technologies, and barriers to therapeutic delivery. By comprehensively reviewing existing evidence and future directions, this review highlights the significant potential of snoRNAs as novel biomarkers and therapeutic targets for the precision diagnosis and treatment of cardiovascular diseases.

Keywords

RNA, small nucleolar / cardiovascular diseases / biomarkers / RNA processing, post-transcriptional

Cite this article

Download citation ▾
Yuzhe Han, Jiazhen Sui, Hongyu Cao, Xinru Jiang, Haifeng Zhang, Yu Wang, Jianxun Wang. Emerging roles and mechanisms of small nucleolar RNA in cardiovascular diseases: research progress. Vessel Plus, 2026, 10 (1) : 26 DOI:10.20517/2574-1209.2025.145

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Stark BA,Desai EC.Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023.J Am Coll Cardiol2025;86:2167-243

[2]

Goh LH,Van Der Lubbe SC.The epidemiology and burden of cardiovascular diseases in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.Lancet Public Health2025;10:e467-79

[3]

Zendjebil S.PCSK9 monoclonal antibodies have come a long way.Curr Atheroscler Rep2024;26:721-32

[4]

Wang R,Loscalzo J.Multiomics network medicine approaches to precision medicine and therapeutics in cardiovascular diseases.Arterioscler Thromb Vasc Biol2023;43:493-503 PMCID:PMC10038904

[5]

Arduini A,Xiao L.Transcriptional profile of the rat cardiovascular system at single-cell resolution.Cell Rep2025;44:115091 PMCID:PMC11781962

[6]

Santovito D.Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease.Nat Rev Cardiol2022;19:620-38

[7]

Lee S.Cardiovascular disease and miRNAs: possible oxidative stress-regulating roles of miRNAs.Antioxidants2024;13:656 PMCID:PMC11200533

[8]

Xie X,Ma S.The role of long non-coding RNAs in cardiovascular diseases: a comprehensive review.Non-Coding RNA Res2025;11:158-87 PMCID:PMC11783329

[9]

Borchardt EK,Gilbert WV.Regulation and function of RNA pseudouridylation in human cells.Annu Rev Genet2020;54:309-36 PMCID:PMC8007080

[10]

Duan C,Zhao J.Small nucleolar RNAs in head and neck squamous cell carcinomas.J Dent Res2024;104:5-16 PMCID:PMC11667199

[11]

Migeot V,Fafard-Couture E.RNase III cleavage sites spread across splice junctions enforce sequential snoRNA processing.EMBO Rep2025;26:4675-90 PMCID:PMC12508059

[12]

Kiss-László Z,Bachellerie J,Kiss T.Site-specific ribose methylation of preribosomal RNA: a novel function for small nucleolar RNAs.Cell1996;85:1077-88

[13]

Cavaillé J,Bachellerie J.Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides.Nature1996;383:732-5

[14]

Wang Y,Zheng Z,Zhang C.Small nucleolar RNAs: biological functions and diseases.MedComm2025;6:e70257 PMCID:PMC12205218

[15]

Lin Z,Li X.Association of DNA methylation and transcriptome reveals epigenetic etiology of heart failure.Funct Integr Genomics2021;22:89-112

[16]

Nossent AY,Wojta J.Plasma levels of snoRNAs are associated with platelet activation in patients with peripheral artery disease.Int J Mol Sci2019;20:5975 PMCID:PMC6929168

[17]

Håkansson KEJ,Trompet S.Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular disease.Cardiovasc Res2019;115:1519-32

[18]

Boivin V,Scott M.The cellular landscape of mid-size noncoding RNA.WIREs RNA2019;10:e1530 PMCID:PMC6619189

[19]

Huang L.The kink-turn in the structural biology of RNA.Q Rev Biophys2018;51:e5

[20]

Huo M,Nakatsu K,Jijiwa M.Subverting the canon: novel cancer-promoting functions and mechanisms for snoRNAs.Int J Mol Sci2024;25:2923 PMCID:PMC10932220

[21]

Deryusheva S.Small, smaller, smallest: minimal structural requirements for a fully functional box C/D modification guide RNA.Biomolecules2019;9:457 PMCID:PMC6770171

[22]

Deschamps-Francoeur G,Abou-Elela S.The snoGloBe interaction predictor reveals a broad spectrum of C/D snoRNA RNA targets.Nucleic Acids Res2022;50:6067-83 PMCID:PMC9226514

[23]

Trucks S,Hengesbach M.Eukaryote specific RNA and protein features facilitate assembly and catalysis of H/ACA snoRNPs.Nucleic Acids Res2021;49:4629-42 PMCID:PMC8096250

[24]

Caton EA,Kamalampeta R.Efficient RNA pseudouridylation by eukaryotic H/ACA ribonucleoproteins requires high affinity binding and correct positioning of guide RNA.Nucleic Acids Res2018;46:905-16 PMCID:PMC5778458

[25]

De Zoysa MD,Katz R.Guide-substrate base-pairing requirement for box H/ACA RNA-guided RNA pseudouridylation.RNA2018;24:1106-17 PMCID:PMC6049503

[26]

Izumikawa K,Ishikawa H.TDP-43 regulates site-specific 2′-O-methylation of U1 and U2 snRNAs via controlling the Cajal body localization of a subset of C/D scaRNAs.Nucleic Acids Res2019;47:2487-505 PMCID:PMC6412121

[27]

Jorjani H,Jedlinski DJ.An updated human snoRNAome.Nucleic Acids Res2016;44:5068-82 PMCID:PMC4914119

[28]

Kishore S,Jedlinski DJ,Jorjani H.Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing.Genome Biol2013;14:R45 PMCID:PMC4053766

[29]

Yin Q,Zhang Y.Long noncoding RNAs with snoRNA ends.Mol Cell2012;48:219-30

[30]

Zhang X,Wang H.Species-specific alternative splicing leads to unique expression of sno-lncRNAs.BMC Genomics2014;15:287 PMCID:PMC4234469

[31]

Kocher MA,Le E.Snord116 post-transcriptionally increases Nhlh2 mRNA Stability: implications for human Prader-Willi syndrome.Hum Mol Genet2021;30:1101-10

[32]

Elliott BA,Ranganathan SV.Modification of messenger RNA by 2′-O-methylation regulates gene expression in vivo.Nat Commun2019;10:3401 PMCID:PMC6667457

[33]

Zhang D,Xu H.Identification of FBLL1 as a neuron-specific RNA 2′-O-methyltransferase mediating neuronal differentiation.Proc Natl Acad Sci USA2024;121:e2406961121 PMCID:PMC11621510

[34]

Li Y,Gao X.2′-O-methylation at internal sites on mRNA promotes mRNA stability.Mol Cell2024;84:2320-36.e6 PMCID:PMC11196006

[35]

Vitali P.Cooperative 2′-O-methylation of the wobble cytidine of human elongator tRNAMet (CAT) by a nucleolar and a Cajal body-specific box C/D RNP.Genes Dev2019;33:741-6 PMCID:PMC6601510

[36]

Zhang M,Bai J.A snoRNA-tRNA modification network governs codon-biased cellular states.Proc Natl Acad Sci USA2023;120:e2312126120 PMCID:PMC10576143

[37]

Nir R,Muramatsu H.A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA.Nucleic Acids Res2022;50:4900-16 PMCID:PMC9122591

[38]

Pan Y,Kierzek R,Yu Y.A Ψ-Ψ codon-anticodon pairing in nonsense suppression and translational recoding.Nat Chem Biol2026;22:983-94

[39]

King TH,Mccully RR.Ribosome structure and activity are altered in cells lacking snoRNPs that form pseudouridines in the peptidyl transferase center.Mol Cell2003;11:425-35

[40]

Sabe SA,Sellke FW.Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.Am J Physiol Heart Circ Physiol2022;322:H819-41 PMCID:PMC9018047

[41]

Yan Q,Wang Z.NAT10-dependent N4-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation.Nat Commun2023;14:6327 PMCID:PMC10564894

[42]

Yu J,Kwon E.Programmable RNA acetylation with CRISPR-Cas13.Nat Chem Biol2026;22:969-82

[43]

Sas-Chen A,Matzov D.Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping.Nature2020;583:638-43 PMCID:PMC8130014

[44]

Sharma S,Watzinger P,Entian K.Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1/THUMPD1.Nucleic Acids Res2015;43:2242-58 PMCID:PMC4344512

[45]

Sharma S,Van Nues R.Specialized box C/D snoRNPs act as antisense guides to target RNA base acetylation.PLoS Genet2017;13:e1006804 PMCID:PMC5464676

[46]

Dudnakova T,Peters R.Mapping targets for small nucleolar RNAs in yeast.Wellcome Open Res2018;3:120 PMCID:PMC6171561

[47]

Lu Z,Lee B.RNA duplex map in living cells reveals higher-order transcriptome structure.Cell2016;165:1267-79 PMCID:PMC5029792

[48]

Bortolin-Cavaillé M,Thalalla Gamage S.Probing small ribosomal subunit RNA helix 45 acetylation across eukaryotic evolution.Nucleic Acids Res2022;50:6284-99 PMCID:PMC9226516

[49]

Thalalla Gamage S,Chu TT.Cytidine acetylation across the tree of life.Acc Chem Res2024;57:338-48 PMCID:PMC11578069

[50]

Liu Y,He K,Barr KW.Splicing inactivation generates hybrid mRNA-snoRNA transcripts targeted by cytoplasmic RNA decay.Proc Natl Acad Sci USA2022;119:e2202473119 PMCID:PMC9351541

[51]

Cihlarova Z,Sobol M.BRAT1 links Integrator and defective RNA processing with neurodegeneration.Nat Commun2022;13:5026 PMCID:PMC9418311

[52]

Huang C,Guo Y.A snoRNA modulates mRNA 3′ end processing and regulates the expression of a subset of mRNAs.Nucleic Acids Res2017;45:8647-60 PMCID:PMC5587809

[53]

Nilsen TW.Expansion of the eukaryotic proteome by alternative splicing.Nature2010;463:457-63 PMCID:PMC3443858

[54]

Bergeron D,Emmerichs A.Intronic small nucleolar RNAs regulate host gene splicing through base pairing with their adjacent intronic sequences.Genome Biol2023;24:160 PMCID:PMC10324135

[55]

Song Z,Schnabl S.Mapping snoRNA-target RNA interactions in an RNA-binding protein-dependent manner with chimeric eCLIP.Genome Biol2025;26:39 PMCID:PMC11863803

[56]

Liu B,Miao BA.snoRNA-facilitated protein secretion revealed by transcriptome-wide snoRNA target identification.Cell2025;188:465-83.e22 PMCID:PMC11761385

[57]

Taft RJ,Lassmann T,Carninci P.Small RNAs derived from snoRNAs.RNA2009;15:1233-40 PMCID:PMC2704076

[58]

Langenberger D,Hoffmann S.Dicer-processed small RNAs: rules and exceptions.J Exp Zool Pt B2012;320:35-46

[59]

Lemus-Diaz N,Bohnsack KE,Bohnsack MT.The human box C/D snoRNA U3 is a miRNA source and miR-U3 regulates expression of sortin nexin 27.Nucleic Acids Res2020;48:8074-89 PMCID:PMC7430653

[60]

Kishore S,Zhang Z.The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing.Hum Mol Genet2010;19:1153-64 PMCID:PMC2838533

[61]

Calandrelli R,Charles Richard JL.Genome-wide analysis of the interplay between chromatin-associated RNA and 3D genome organization in human cells.Nat Commun2023;14:6519 PMCID:PMC10579264

[62]

Schubert T,Diermeier S.Df31 protein and snoRNAs maintain accessible higher-order structures of chromatin.Mol Cell2012;48:434-44

[63]

Lin X,Wolfe KF.XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites.Nucleic Acids Res2025;53:gkaf086 PMCID:PMC11838041

[64]

Kim D,Nagari A,Challa S.Activation of PARP-1 by snoRNAs controls ribosome biogenesis and cell growth via the RNA helicase DDX21.Mol Cell2019;75:1270-85.e14 PMCID:PMC6754283

[65]

Han C,Luo X.Chromatin-associated orphan snoRNA regulates DNA damage-mediated differentiation via a non-canonical complex.Cell Rep2022;38:110421

[66]

Shi J,Zhang J.NAT10 is involved in cardiac remodeling through ac4C-mediated transcriptomic regulation.Circ Res2023;133:989-1002

[67]

Li P,Chen T.Dysregulated Rbfox2 produces aberrant splicing of CaV1.2 calcium channel in diabetes-induced cardiac hypertrophy.Cardiovasc Diabetol2023;22:168 PMCID:PMC10324275

[68]

Vad OB,Liss M.Loss of cardiac splicing regulator RBM20 is associated with early-onset atrial fibrillation.JACC Basic Transl Sci2024;9:163-80 PMCID:PMC10950405

[69]

Deng Z,Hu S.sdRNA-D43 derived from small nucleolar RNA snoRD43 improves chondrocyte senescence and osteoarthritis progression by negatively regulating PINK1/Parkin-mediated mitophagy pathway via dual-targeting NRF1 and WIPI2.Cell Commun Signal2025;23:77 PMCID:PMC11817878

[70]

Meng X,Zhang K.Congenital heart disease: types, pathophysiology, diagnosis, and treatment options.MedComm2024;5:e631 PMCID:PMC11224996

[71]

Rao E.Genetics of congenital heart disease: a narrative review of challenges and strategies in identifying novel genes.Cureus2025;17:e91674 PMCID:PMC12412710

[72]

Wang H,Li Y.Non-coding RNAs in congenital heart disease and placental development: Bridging molecular mechanisms to clinical biomarkers and therapies.Non-coding RNA Res2026;16:1-20 PMCID:PMC12510048

[73]

Patil P,Uechi T.scaRNAs regulate splicing and vertebrate heart development.Biochim Biophys Acta Mol Basis Dis2015;1852:1619-29

[74]

O'brien JE,Zhou X.Noncoding RNA expression in myocardium from infants with tetralogy of fallot.Circ Cardiovasc Genet2012;5:279-86

[75]

Ogren A,Marshall J,Bittel DC.Snord94 expression level alters methylation at C62 in snRNA U6.PLoS ONE2019;14:e0226035 PMCID:PMC6894857

[76]

Brown M,Filla M,O’brien JE.scaRNA1 expression levels affect alternative splicing of mRNA.Genes2025;16:864 PMCID:PMC12385260

[77]

Nagasawa CK,Marshall J,Bittel DC.scaRNA1 levels alter pseudouridylation in spliceosomal RNA U2 affecting alternative mRNA splicing and embryonic development.Pediatr Cardiol2020;41:341-9

[78]

Lei W,Li H.An interpretable deep learning model for first-trimester fetal cardiac screening.NPJ Digit Med2025;9:43 PMCID:PMC12800213

[79]

Huang S,Li Q.Cardiomyopathy: pathogenesis and therapeutic interventions.MedComm2024;5:e772 PMCID:PMC11502724

[80]

Shimoda M,Obata Y,Kono T.Imprinting of a small nucleolar RNA gene on mouse chromosome 12.Genomics2002;79:483-6

[81]

Siira SJ,Richman TR.Concerted regulation of mitochondrial and nuclear non-coding RNAs by a dual-targeted RNase Z.EMBO Rep2018;19:EMBR201846198 PMCID:PMC6172459

[82]

Tallo CA,Yamamoto AH.Heat shock proteins and small nucleolar RNAs are dysregulated in a Drosophila model for feline hypertrophic cardiomyopathy.G32021;11:jkaa014 PMCID:PMC7849908

[83]

James V,Lea D.Transcriptomic analysis of cardiomyocyte extracellular vesicles in hypertrophic cardiomyopathy reveals differential snoRNA cargo.Stem Cells Dev2021;30:1215-27 PMCID:PMC8742282

[84]

Epstein FH,Dzau VJ.The emerging concept of vascular remodeling.N Engl J Med1994;330:1431-8

[85]

Wang S,Zhao A.A novel hidden protein p-414aa encoded by circSETD2(14,15) inhibits vascular remodeling.Circulation2025;151:1568-82

[86]

Liu P,Shi Y.Changes in the small RNA expression in endothelial cells in response to inflammatory stimulation.Oxid Med Cell Longev2021;2021:8845520 PMCID:PMC8133845

[87]

Yang X,Wang H.SNORD45A affects content of HIF-1α and promotes endothelial angiogenic function.Appl Biochem Biotechnol2024;196:7185-97

[88]

Van Ingen E,Van Der Bent ML.C/D box snoRNA SNORD113-6/AF357425 plays a dual role in integrin signalling and arterial fibroblast function via pre-mRNA processing and 2′O-ribose methylation.Hum Mol Genet2022;31:1051-66 PMCID:PMC8976432

[89]

Van Ingen E,Woudenberg T.C/D box snoRNA SNORD113-6 guides 2′-O-methylation and protects against site-specific fragmentation of tRNALeu(TAA) in vascular remodeling.Mol Ther Nucleic Acids2022;30:162-72 PMCID:PMC9547152

[90]

Rahimi AM,Hoyer-Fender S.Heterogeneity of the NIH3T3 fibroblast cell line.Cells2022;11:2677 PMCID:PMC9455036

[91]

Youness M,Nagaraju CK.Location and aetiology are determinants of fibroblast activation and heterogeneity in the failing human heart.Genome Med2025;17:155 PMCID:PMC12751894

[92]

Amrute JM,Penna V.Targeting immune-fibroblast cell communication in heart failure.Nature2024;635:423-33 PMCID:PMC12334188

[93]

Chauhan W,Ferdowsi S,Zennadi R.Red blood cell Rpl13a small noncoding nucleolar RNAs guides 2'-O-methylation on peroxidasin messenger RNA promoting venous thrombosis in aging.J Thromb Haemost2025;S1538783625001357 PMCID:PMC12353407

[94]

Chauhan W,Sudharshan S.Rpl13a snoRNAs-regulated NADPH oxidase 1-dependent ROS generation: a novel RBC pathway mediating complement C3a deposition and triggering thrombosis in aging and venous blood clotting disorders.Free Radic Biol Med2025;230:138-50 PMCID:PMC11936428

[95]

Engelen SE,Zurke Y.Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?.Nat Rev Cardiol2022;19:522-42 PMCID:PMC8802279

[96]

Yao Z,Dardari ZA.Association between cigarette smoking and subclinical markers of cardiovascular harm.J Am Coll Cardiol2025;85:1018-34 PMCID:PMC12812482

[97]

Keshawarz A,Guan W.Longitudinal change in blood DNA epigenetic signature after smoking cessation.Epigenetics2021;17:1098-109 PMCID:PMC9542417

[98]

Aboyans V,Chastaingt L.Peripheral artery disease.Nat Rev Dis Primers2025;11:68

[99]

Golledge J.Update on the pathophysiology and medical treatment of peripheral artery disease.Nat Rev Cardiol2022;19:456-74

[100]

Håkansson KEJ,Simons KH,Jensen J.Circulating small non-coding RNAs as biomarkers for recovery after exhaustive or repetitive exercise.Front Physiol2018;9:1136

[101]

Jain K,Gu SX,Hwa J.Demographic diversity in platelet function and response to antiplatelet therapy.Trends Pharmacol Sci2025;46:78-93 PMCID:PMC11710996

[102]

Sayer M,Dhaun N.Novel pharmacological approaches to lowering blood pressure and managing hypertension.Nat Rev Cardiol2025;22:649-63

[103]

Delgado-Olguín P,Li X.Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis.Nat Genet2012;44:343-7 PMCID:PMC3288669

[104]

He A,Cao J.Polycomb repressive complex 2 regulates normal development of the mouse heart.Circ Res2012;110:406-15 PMCID:PMC3282145

[105]

Wang S,Li S.EZH2 dynamically associates with non-coding RNAs in mouse hearts after acute angiotensin II treatment.Front Cardiovasc Med2021;8:585691 PMCID:PMC7959742

[106]

Witte F,Mattioli CC.A trans locus causes a ribosomopathy in hypertrophic hearts that affects mRNA translation in a protein length-dependent fashion.Genome Biol2021;22:191 PMCID:PMC8240307

[107]

Wang J,Zhang S.Comprehensive characterization of small noncoding RNA profiles in hypoxia-induced pulmonary hypertension (HPH) rat tissues.iScience2024;27:108815 PMCID:PMC10844824

[108]

Heusch G.The spleen in ischaemic heart disease.Nat Rev Cardiol2025;22:497-509

[109]

Mamaev NN,Amineva K.AgNORs in cardiomyocytes from surgical patients with coronary heart disease.Mol Pathol1998;51:218-21 PMCID:PMC395640

[110]

Freedman JE,Mick E.Corrigendum: Diverse human extracellular RNAs are widely detected in human plasma.Nat Commun2016;7:11902 PMCID:PMC4895790

[111]

Mick E,Tanriverdi K.Stroke and circulating extracellular RNAs.Stroke2017;48:828-34 PMCID:PMC5373984

[112]

Chapman AR,Boeddinghaus J,Fox KAA.Type 2 myocardial infarction: challenges in diagnosis and treatment.Eur Heart J2025;46:504-17 PMCID:PMC11804249

[113]

Pan W,Guan Y.MCA-net: a multi-task channel attention network for Myocardial infarction detection and location using 12-lead ECGs.Comput Biol Med2022;150:106199

[114]

Shumliakivska M,Muhly-Reinholz M.The long non-coding RNA Snhg15 protects the heart after myocardial infarction.J Mol Cell Cardiol2026;210:72-82

[115]

Wang S,Chen X,Zhu X.Long noncoding RNA SNHG4 attenuates the injury of myocardial infarction via regulating miR-148b-3p/DUSP1 axis.Cardiovasc Ther2022;2022:1-15 PMCID:PMC9744614

[116]

Hobby ARH,Eaton DM.Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype.Am J Physiol Heart Circ Physiol2021;321:H684-701 PMCID:PMC8794230

[117]

Yang Y,Troupes CD.miR-182/183-Rasa1 axis induced macrophage polarization and redox regulation promotes repair after ischemic cardiac injury.Redox Biol2023;67:102909 PMCID:PMC10570148

[118]

Schena GJ,Hildebrand AN.Cortical bone stem cell-derived exosomes’ therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.Am J Physiol Heart Circ Physiol2021;321:H1014-29 PMCID:PMC8793944

[119]

Zeng Y,Li J.Small non-coding RNA signatures in atrial appendages of patients with atrial fibrillation.J Cell Mol Med2024;28:e18483 PMCID:PMC11193094

[120]

Bauersachs J,Lindenfeld J.The year in cardiovascular medicine 2021: heart failure and cardiomyopathies.Eur Heart J2022;43:367-76 PMCID:PMC9383181

[121]

Li X,Xie L,Song X.Identification of four snoRNAs (SNORD16, SNORA73B, SCARNA4, and SNORD49B) as novel non-invasive biomarkers for diagnosis of breast cancer.Cancer Cell Int2024;24:55 PMCID:PMC10840236

[122]

Grützmann K,Krüger A.Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles.Biol Direct2024;19:38 PMCID:PMC11089706

[123]

Rambaldelli G,Venturi G.Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells.Non-Coding RNA Res2025;13:153-61 PMCID:PMC12152556

[124]

Chabronova A,Hoang DM.SnoRNAs in cardiovascular development, function, and disease.Trends Mol Med2024;30:562-78

[125]

Yuan S,Wang Y,Chu L.An oncolytic adenovirus expressing SNORD44 and GAS5 exhibits antitumor effect in colorectal cancer cells.Hum Gene Ther2017;28:690-700

[126]

Wang W,Mittal SK.Significance of preexisting vector immunity and activation of innate responses for adenoviral vector-based therapy.Viruses2022;14:2727 PMCID:PMC9787786

[127]

Wang X,Li J,Cheng L.Inorganic nanomaterials with rapid clearance for biomedical applications.Chem Soc Rev2021;50:8669-742

[128]

Xuan J,Chen Z.RMBase v3.0: decode the landscape, mechanisms and functions of RNA modifications.Nucleic Acids Res2024;52:D273-84 PMCID:PMC10767931

[129]

Zhang L,Hu X.Graph convolutional network and contrastive learning small nucleolar RNA (snoRNA) disease associations (GCLSDA): predicting snoRNA-disease associations via graph convolutional network and contrastive learning.Int J Mol Sci2023;24:14429 PMCID:PMC10572952

[130]

Bergeron D,Fafard-Couture É.snoDB 2.0: an enhanced interactive database, specializing in human snoRNAs.Nucleic Acids Res2023;51:D291-6 PMCID:PMC9825428

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/